Article info
PDFReview
Emergencies and critical issues in Parkinson’s disease
- Correspondence to Professor Eduardo Tolosa, Neurology, Hospital Clinic de Barcelona, Barcelona 8036, Spain; etolosa{at}clinic.ub.es
Citation
Emergencies and critical issues in Parkinson’s disease
Publication history
- Accepted July 19, 2019
- First published August 19, 2019.
Online issue publication
January 14, 2020
Article Versions
- Previous version (19 August 2019).
- Previous version (16 September 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease
- When the going gets tough: how to select patients with Parkinson's disease for advanced therapies
- Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Parkinson’s disease: etiopathogenesis and treatment
- Initial drug treatment in Parkinson’s disease
- Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
- Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases
- Deep brain stimulation for movement disorders
- Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial